This site is intended for healthcare professionals
News

CTI BioPharma initiates rolling submission of NDA for pacritinib in myelofibrosis patients with severe thrombocytopenia.

Read time: 1 mins
Last updated:14th Oct 2020
Published:14th Oct 2020
Condition: Myelofibrosis
Type: drug
Register free for full access to medthority.com